切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2023, Vol. 17 ›› Issue (03) : 182 -185. doi: 10.3877/cma.j.issn.1674-0793.2023.03.005

论著

右美托咪定与曲马多分别复合罗哌卡因在全麻下结肠癌根治术中的应用
李志伟(), 向琪, 彭胜男, 郭玲, 孙贱根, 杨川   
  1. 620010 四川省眉山市中医医院麻醉手术中心
    628000 四川省广元市第二人民医院麻醉科
  • 收稿日期:2022-08-31 出版日期:2023-06-01
  • 通信作者: 李志伟
  • 基金资助:
    2018年四川省卫生和计划生育委员会科研课题项目(18PJ184)

Application of dexmedetomidine versus tramadol combined with ropivacaine in the radical operation of colon cancer under general anesthesia

Zhiwei Li(), Qi Xiang, Shengnan Peng, Ling Guo, Jiangen Sun, Chuan Yang   

  1. Department of Anesthesiology Center, Meishan Hospital of Traditional Chinese Medicine, Meishan 620010, China
    Department of Anesthesiology, Guangyuan Second People’s Hospital, Guangyuan 628000, China
  • Received:2022-08-31 Published:2023-06-01
  • Corresponding author: Zhiwei Li
引用本文:

李志伟, 向琪, 彭胜男, 郭玲, 孙贱根, 杨川. 右美托咪定与曲马多分别复合罗哌卡因在全麻下结肠癌根治术中的应用[J/OL]. 中华普通外科学文献(电子版), 2023, 17(03): 182-185.

Zhiwei Li, Qi Xiang, Shengnan Peng, Ling Guo, Jiangen Sun, Chuan Yang. Application of dexmedetomidine versus tramadol combined with ropivacaine in the radical operation of colon cancer under general anesthesia[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2023, 17(03): 182-185.

目的

探讨右美托咪定与曲马多分别复合罗哌卡因在全麻下结肠癌根治术中的应用效果。

方法

回顾性分析2019年1月至2020年6月四川省眉山市中医医院83例行腹腔镜下结肠癌根治性切除术患者的临床资料,其中45例予以右美托咪定复合常规全麻(A组),38例予以曲马多复合常规全麻(B组)。观察指标包括手术时间、麻醉时间、术中麻醉用药量、术中麻醉效果、术后躁动、寒战发生率、麻醉后苏醒时间及不良反应发生率。

结果

A组右美托咪定用药剂量为(98.91±10.26)μg,B组曲马多用药剂量为(129.10±12.35) mg。两组手术时间、麻醉时间、术中咪达唑仑、丙泊酚、舒芬太尼、苯磺酸阿曲库铵用药量、麻醉后苏醒时间差异均无统计学意义(t=0.546、0.213、0.707、0.311、0.469、0.145、0.547,P=0.587、0.832、0.482、0.756、0.628、0.897、0.586)。A组麻醉效果满意率为97.78%,高于B组的84.21%(χ2=3.975,P=0.033);A组术后躁动、寒战发生率分别为2.22%、4.44%,均分别低于B组的18.42%、26.32%(χ2=4.487、6.298,P=0.034、0.012);A组总不良反应率低于B组(17.78% vs 60.53%, χ2=14.315,P<0.001)。

结论

右美托咪定复合常规全麻应用于腹腔镜下结肠癌根治性切除术中,可增强术中麻醉效果,减少术后躁动和寒战发生情况,是一种合理的麻醉方法。

Objective

To explore the application of dexmedetomidine and tramadol combined with ropivacaine in the radical operation of colon cancer under general anesthesia effect.

Methods

The clinical data of 83 patients undergoing laparoscopic radical resection of colon cancer in Meishan City Hospital of Traditional Chinese Medicine from January 2019 to June 2020 were retrospectively analyzed. Among them, 45 patients were treated with dexmedetomidine combined with conventional general anesthesia (group A); the other 38 cases were treated with tramadol combined with general anesthesia (group B). The observation indexes included the operation time, anesthesia time, the amount of anesthetic drugs used during the operation, the effect of anesthesia during the operation, the incidence of postoperative restlessness, shiver, the recovery time after anesthesia and the incidence of adverse reactions.

Results

The dosage of dexmedetomidine in group A was (98.91±10.26) μg, and the dosage of tramadol in group B was (129.10±12.35) mg. There were no significant differences in the operation time, anesthesia time, dosage of midazolam, propofol, sufentanil, cisatracurium and recovery time between the two groups (t=0.546, 0.213, 0.707, 0.311, 0.469, 0.145, 0.547, P=0.587, 0.832, 0.482, 0.756, 0.628, 0.897, 0.586). The satisfaction rate of anesthesia effect in group A was 97.78%, higher than that of 84.21% in group B (χ2=3.975, P=0.033). The incidence of postoperative agitation and chills in group A were 2.22% and 4.44%, which were lower than those of 18.42% and 26.32% in group B respectively (χ2=4.487, 6.298; P=0.034, 0.012). The adverse reaction rate in group A was lower than that in group B (17.78% vs 60.53%, χ2=14.315, P<0.001).

Conclusion

Dexmedetomidine combined with conventional general anesthesia in laparoscopic radical resection of colon cancer under general anesthesia can enhance the anesthetic effect during operation and reduce the occurrence of postoperative agitation and shivering, which is a reasonable anesthetic method.

表1 两组行结肠癌根治性切除术患者一般资料比较
表2 两组行结肠癌根治性切除术患者手术情况的对比
表3 两组行结肠癌根治性切除术患者不良反应发生率[例(%)]
[1]
杜灵彬, 李辉章, 王悠清, 等. 2013年中国结直肠癌发病与死亡分析[J]. 中华肿瘤杂志, 2017, 39(9): 701-706.
[2]
Chen YW, Huang MT, Chang TC. Long term outcomes of simultaneous laparoscopic versus open resection for colorectal cancer with synchronous liver metastases[J]. Asian J Surg, 2019, 42(1): 217-223.
[3]
朱利君, 俞玉龙, 王钰, 等. 超声引导下腹直肌后鞘阻滞联合腹横肌阻滞对开腹结直肠癌术患者应激反应的影响[J]. 中华全科医学, 2019, 17(9): 1515-1517.
[4]
Kinugasa H, Higashi R, Miyahara K, et al. Dexmedetomidine for conscious sedation with colorectal endoscopic submucosal dissection: A prospective double-blind randomized controlled study[J]. Clin Transl Gastroenterol, 2018, 9(7): 167.
[5]
Lee SH, Sim WS, Kim GE, et al. Randomized trial of subfascial infusion of ropivacaine for early recovery in laparoscopic colorectal cancer surgery[J]. Korean J Anesthesiol, 2016, 69(6): 604-613.
[6]
焦烨, 朱宏, 许军. 罗哌卡因联合右美托咪啶腹腔喷洒对腹腔镜下结直肠癌手术术后疼痛的影响[J]. 临床和实验医学杂志, 2018, 17(2): 218-220.
[7]
周桥灵, 戴鹏, 刘洪珍, 等. 3种浓度罗哌卡因的竖脊肌平面阻滞对胸科手术术后镇痛效果的比较[J]. 重庆医学, 2020, 49(7): 1078-1081.
[8]
Gao H, Meng XY, Wang HQ, et al. Association between anaesthetic technique and oncological outcomes after colorectal carcinoma liver metastasis resection[J]. Int J Med Sci, 2019, 16(2): 337-342.
[9]
马燕, 李仲然, 马开喜, 等. 右美托咪定复合罗哌卡因腹横肌平面阻滞对老年患者结直肠癌根治术后早期恢复质量的影响[J]. 临床麻醉学杂志, 2020, 36(2): 148-151.
[10]
Zhang J, Liu G, Zhang F, et al. Analysis of postoperative cognitive dysfunction and influencing factors of dexmedetomidine anesthesia in elderly patients with colorectal cancer[J]. Oncol Lett, 2019, 18(3): 3058-3064.
[11]
Chen HY, Li GH, Tan GC, et al. Dexmedetomidine enhances hypoxia-induced cancer cell progression[J]. Exp Ther Med, 2019, 18(6): 4820-4828.
[12]
吴滨, 刘延超, 胡洪凭, 等. 右美托咪定复合酮咯酸氨丁三醇超前镇痛对腹腔镜胃癌根治患者术后镇痛的影响[J]. 中国现代普通外科进展, 2019, 22(6): 439-444.
[13]
高瑞, 冯慧悦, 马益平, 等. 罗哌卡因复合右美托咪定腹横肌平面阻滞对小儿腹腔镜阑尾切除术术后疼痛的影响[J]. 国际麻醉学与复苏杂志, 2018, 39(7): 633-637.
[14]
Zhang Y, Ran K, Zhang SB, et al. Dexmedetomidine may upregulate the expression of caveolin-1 in lung tissues of rats with sepsis and improve the short-term outcome[J]. Mol Med Rep, 2017, 15(2): 635-642.
[15]
Guan YJ, Wei L, Liao Q, et al. Pain management after ambulatory surgery: A prospective, multicenter, randomized, double-blinded parallel controlled trial comparing nalbuphine and tramadol[J]. BMC Anesthesiol, 2020, 20(1): 204.
[16]
Wang J, Wang Z, Liu J, et al. Intravenous dexmedetomidine versus tramadol for treatment of shivering after spinal anesthesia: A meta-analysis of randomized controlled trials[J]. BMC Anesthesiol, 2020, 20(1): 104.
[17]
Qin Z, Xiang C, Li H, et al. The impact of dexmedetomidine added to ropivicaine for transversus abdominis plane block on stress response in laparoscopic surgery: A randomized controlled trial[J]. BMC Anesthesiol, 2019, 19(1): 181.
[1] 燕速, 霍博文. 腹腔镜食管胃结合部腺癌根治性切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 13-13.
[2] 母德安, 李凯, 张志远, 张伟. 超微创器械辅助单孔腹腔镜下脾部分切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 14-14.
[3] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[4] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[5] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[6] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[7] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[8] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[9] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[10] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[11] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[12] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
[13] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[14] 李凯, 陈淋, 苏怀东, 向涵, 张伟. 超微创器械在改良单孔腹腔镜巨大肝囊肿开窗引流及胆囊切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 144-144.
[15] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?